Dr. Jeremy M. Levin, an iconic biotech thought-leader who first introduced immuno-oncology to the world 10 years ago. He is currently CEO and Chairman of OVID Therapeutics, Inc., and Chair of the global Biotechnology Innovation Organization (BIO). Could a coronavirus vaccine rehab the pharmaceutical industry’s reputation despite drug price increases?